Business Context and Reporting Period
Company: HEALTHSOUTH Corporation (Note: Input metadata referenced "Encompass Health Corp," but the filing text identifies the registrant as HEALTHSOUTH Corporation).
Reporting Period: Quarterly report (Form 10-Q) for the period ended September 30, 1995.
Business Overview: The Company provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, and medical centers. As of September 30, 1995, operations included 509 locations across 39 states, the District of Columbia, and Ontario, Canada.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1995 | Nine Months Ended Sep 30, 1995 | Nine Months Ended Sep 30, 1994 |
|---|---|---|---|
| Revenues | $392,740,000 | $1,109,689,000 | $902,268,000 |
| Net Income | $27,133,000 | $44,910,000 | $45,356,000 |
| EPS (Diluted) | $0.30 | $0.51 | $0.54 |
| Operating Cash Flow | N/A | $127,313,000 | $107,481,000 |
| Long-Term Debt | $1,386,450,000 | $1,386,450,000 | $1,017,696,000 |
| Cash & Equivalents | $86,952,000 | $86,952,000 | $67,095,000 |
| Working Capital | $299,157,000 | $299,157,000 | $231,327,000 |
Margins: Operating expenses at the unit level were 70.2% of revenues for the quarter and 71.1% for the nine-month period. The effective tax rate for the quarter was 38.0%.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 23.5% for the quarter and 23.0% for the nine-month period compared to 1994. This growth is driven by increased patient volume, the acquisition of the NovaCare rehabilitation hospitals division, and the addition of new outpatient centers.
- Profitability: Net income for the quarter increased significantly to $27.1 million from $16.1 million in the prior year. However, net income for the nine-month period remained relatively flat ($44.9 million vs. $45.4 million) due to significant non-recurring expenses.
- Debt Levels: Long-term debt increased by approximately $369 million year-over-year, primarily due to increased borrowings under a $1 billion revolving credit facility to fund acquisitions and operations.
- Acquisitions: The Company completed the merger with Surgical Health Corporation (SHC) and the acquisition of NovaCare's rehabilitation division. Financial statements have been restated to include SHC results as a pooling of interests.
Guidance, Outlook, and Risks
- Unusual Items: The nine-month results included $29.2 million in merger costs and an $11.2 million loss on impairment of assets related to six SHC facilities where projected cash flows did not support book value.
- Capital Expenditures: Management anticipates spending approximately $80 million on new outpatient facilities and $70 million on inpatient projects over the next twelve months.
- Recent Transactions (Post-Period):
- Issued 14,950,000 shares of Common Stock on October 3, 1995, with net proceeds of ~$335 million, largely used to reduce debt.
- Agreed to acquire Surgical Care Affiliates, Inc. (SCA) in a stock-for-stock merger valued at ~$1.2 billion (expected completion early 1996).
- Agreed to acquire Caremark Orthopedic Services Inc. for ~$127.5 million in cash (expected completion by year-end 1995).
- Liquidity: The Company maintains a $1 billion revolving credit facility with $935 million drawn as of September 30, 1995. Management believes existing cash, operating cash flow, and credit facilities are sufficient for future requirements.
Investor Verification Checklist
- Debt Servicing: Verify the impact of the $935 million draw on the $1 billion credit facility and the recent $319 million debt reduction from the October stock offering.
- Acquisition Integration: Assess the integration progress and financial performance of the SHC and NovaCare acquisitions, particularly regarding the $11.2 million impairment charge.
- Regulatory Approvals: Monitor the status of regulatory approvals required for the pending $1.2 billion SCA merger and the Caremark acquisition.
- Reimbursement Rates: Review the concentration of revenue from Medicare (39.4% in Q3) and Medicaid (3.3% in Q3) and potential risks associated with retroactive adjustments.
- Stock Dilution: Evaluate the impact of the recent 14.95 million share issuance and the pending stock-for-stock SCA merger on future earnings per share.